非酒精性脂肪性肝病中晚期组织学的非侵入性标志物：我们做到了吗？ - Suppr

Suppr

超能文献

Noninvasive markers of advanced histology in nonalcoholic fatty liver disease: are we there yet?

作者信息

Wilson Spencer, Chalasani Naga

出版信息

Gastroenterology. 2007 Oct;133(4):1377-8; discussion 1378-9. doi: 10.1053/j.gastro.2007.08.045.

DOI:10.1053/j.gastro.2007.08.045

PMID:17919509

Abstract

摘要

相似文献

Noninvasive markers of advanced histology in nonalcoholic fatty liver disease: are we there yet?

Gastroenterology. 2007 Oct;133(4):1377-8; discussion 1378-9. doi: 10.1053/j.gastro.2007.08.045.

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

Dig Liver Dis. 2008 May;40(5):371-8. doi: 10.1016/j.dld.2007.10.019. Epub 2007 Dec 20.

Nonalcoholic fatty liver disease: emerging mechanisms and consequences.

Curr Opin Clin Nutr Metab Care. 2008 Mar;11(2):128-33. doi: 10.1097/MCO.0b013e3282f44bf4.

The impact of bariatric surgery on nonalcoholic fatty liver disease.

Curr Opin Clin Nutr Metab Care. 2008 May;11(3):267-74. doi: 10.1097/MCO.0b013e3282fbd33f.

Recent advances in nonalcholic fatty liver disease.

Curr Opin Gastroenterol. 2008 May;24(3):320-7. doi: 10.1097/MOG.0b013e3282fbccf2.

Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.

Curr Opin Clin Nutr Metab Care. 2008 Jul;11(4):477-82. doi: 10.1097/MCO.0b013e328302f3ec.

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.

Curr Opin Lipidol. 2008 Jun;19(3):295-300. doi: 10.1097/MOL.0b013e3282ff5e55.

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

Clin Gastroenterol Hepatol. 2008 Jul;6(7):828-31. doi: 10.1016/j.cgh.2008.03.005. Epub 2008 Jun 4.

Nonalcoholic fatty liver disease in type 2 diabetes mellitus.

Curr Opin Endocrinol Diabetes Obes. 2009 Apr;16(2):141-9. doi: 10.1097/MED.0b013e3283293015.

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease.

Med Sci Monit. 2009 Apr;15(4):HY1-5.

引用本文的文献

Noninvasive Assessment of the Severity of Liver Fibrosis in MASLD Patients with Long-Standing Type 2 Diabetes.

J Gen Intern Med. 2025 Jan 22. doi: 10.1007/s11606-025-09348-2.

Nonalcoholic fatty liver disease: Diagnostic biomarkers.

World J Gastrointest Pathophysiol. 2017 May 15;8(2):11-26. doi: 10.4291/wjgp.v8.i2.11.

Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene.

J Gastroenterol. 2014 Jun;49(6):1056-64. doi: 10.1007/s00535-013-0850-x. Epub 2013 Jun 26.

Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.

J Clin Gastroenterol. 2011 Jan;45(1):55-8. doi: 10.1097/MCG.0b013e3181dd1348.

Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.

Obesity (Silver Spring). 2009 Sep;17(9):1696-701. doi: 10.1038/oby.2009.89. Epub 2009 Apr 9.

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Hepatology. 2009 Jan;49(1):306-17. doi: 10.1002/hep.22603.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验